0001232583-17-000006.txt : 20170605 0001232583-17-000006.hdr.sgml : 20170605 20170605181213 ACCESSION NUMBER: 0001232583-17-000006 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20170601 FILED AS OF DATE: 20170605 DATE AS OF CHANGE: 20170605 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: Evolent Health, Inc. CENTRAL INDEX KEY: 0001628908 STANDARD INDUSTRIAL CLASSIFICATION: SERVICES-MANAGEMENT SERVICES [8741] IRS NUMBER: 320454912 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 800 NORTH GLEBE RD, SUITE 500 CITY: ARLINGTON STATE: VA ZIP: 22203 BUSINESS PHONE: 571-389-6000 MAIL ADDRESS: STREET 1: 800 NORTH GLEBE RD, SUITE 500 CITY: ARLINGTON STATE: VA ZIP: 22203 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: WIGGINTON STEVE CENTRAL INDEX KEY: 0001232583 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 001-37415 FILM NUMBER: 17892503 MAIL ADDRESS: STREET 1: 800 N. GLEBE ROAD, SUITE 500 CITY: ARLINGTON STATE: VA ZIP: 22203 4 1 primary_doc.xml PRIMARY DOCUMENT X0306 4 2017-06-01 0 0001628908 Evolent Health, Inc. EVH 0001232583 WIGGINTON STEVE C/O EVOLENT HEALTH, INC. 800 N. GLEBE ROAD, SUITE 500 ARLINGTON VA 22203 0 1 0 0 CEO, Valence Health Class A Common Stock 2017-06-01 4 M 0 6000 3.84 A 19370 D Class A Common Stock 2017-06-01 4 S 0 1600 23.51 D 17770 D Class A Common Stock 2017-06-01 4 S 0 4400 24.36 D 13370 D Class A Common Stock Option (right to buy) 3.84 2017-06-01 4 M 0 6000 0 D 2024-04-01 Class A Common Stock 6000 411680 D The transactions reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on September 12, 2016. Includes restricted stock units under awards reported on Table 1 of Form 4s previously filed with the Securities and Exchange Commission. The price reported in Column 4 is a weighted average. These shares were sold in multiple transactions at prices ranging from $23.00-$23.85, inclusive. The reporting person undertakes to provide to Evolent Health, Inc., any security holder of Evolent Health, Inc., or the Staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate prices within the range set forth in this footnote. The price reported in Column 4 is a weighted average. These shares were sold in multiple transactions at prices ranging from $24.00-$24.60, inclusive. The reporting person undertakes to provide to Evolent Health, Inc., any security holder of Evolent Health, Inc., or the Staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote. The Class A Common Stock Options exercised vested on October 1, 2014. /s/ Jonathan Weinberg, Attorney-in-fact 2017-06-05